Composition comprising avermectin compounds without solid fatty substances
US10744147B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Nov 23, 2017 |
| Grant date | Aug 18, 2020 |
| Priority date | — |
| Expiry date | Nov 23, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/107
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Composition comprising avermectin compounds without solid fatty substances The invention relates to a dermatological or pharmaceutical composition comprising at least one aqueous phase and at least one active phase comprising at least one active compound chosen from avermectin compounds and at least one solvent and/or propenetrating agent of avermectin compounds, where the composition comprises less than 3% by weight of solid fatty substances at room temperature and at atmospheric pressure, relative to the total weight of the composition. The invention relates also to the composition for use in the treatment of rosacea, of common acne, of seborrheic dermatitis, of perioral dermatitis, of acneiform rashes, of transient acantholytic dermatosis, of acne necrotica miliaris and of atopic dermatitis, and preferably for use in the treatment of rosacea. Finally, the invention relates to a method for preparing the composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.